Dr. Erkut Borazanci, MD
Claim this profileHonor Health Research Institute
Expert in Pancreatic Cancer
Studies Solid Tumors
16 reported clinical trials
27 drugs studied
Area of expertise
1Pancreatic Cancer
Global LeaderStage IV
Stage III
CA19-9 positive
2Solid Tumors
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Erkut Borazanci, MD is currently running
Early Detection
for Pancreatic Cancer
The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying pathogenic/likely pathogenic germline variants (PGVs) in genes linked to PDAC risk for longitudinal follow up.
Recruiting1 award N/A10 criteria
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting3 awards Phase 1 & 211 criteria
More about Erkut Borazanci, MD
Clinical Trial Related2 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Erkut Borazanci, MD has experience with
- Gemcitabine
- Botensilimab
- Lurbinectedin
- HCW9218
- Minnelide™ Capsules
- SM08502
Breakdown of trials Erkut Borazanci, MD has run
Pancreatic Cancer
Solid Tumors
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erkut Borazanci, MD specialize in?
Erkut Borazanci, MD focuses on Pancreatic Cancer and Solid Tumors. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Erkut Borazanci, MD currently recruiting for clinical trials?
Yes, Erkut Borazanci, MD is currently recruiting for 5 clinical trials in Scottsdale Arizona. If you're interested in participating, you should apply.
Are there any treatments that Erkut Borazanci, MD has studied deeply?
Yes, Erkut Borazanci, MD has studied treatments such as Gemcitabine, Botensilimab, Lurbinectedin.
What is the best way to schedule an appointment with Erkut Borazanci, MD?
Apply for one of the trials that Erkut Borazanci, MD is conducting.
What is the office address of Erkut Borazanci, MD?
The office of Erkut Borazanci, MD is located at: Honor Health Research Institute, Scottsdale, Arizona 85258 United States. This is the address for their practice at the Honor Health Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.